Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany:
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen ; Nürnberg
Friedrich-Alexander-Universität Erlangen-Nürnberg
2022
|
| Schlagworte: | |
| Online-Zugang: | Volltext Volltext Volltext |
| Beschreibung: | 1 Online-Ressource |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV048871078 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 230322s2022 gw |||| o||u| ||||||eng d | ||
| 015 | |a 23,O02 |2 dnb | ||
| 016 | 7 | |a 1279277416 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-214048 |2 urn | |
| 035 | |a (OCoLC)1374570946 | ||
| 035 | |a (DE-599)DNB1279277416 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |8 3\p |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 084 | |8 1\p |a 616.7 |2 23ksdnb | ||
| 084 | |8 2\p |a 610 |2 23sdnb | ||
| 100 | 1 | |a van der Keylen, Piet |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany |c Piet van der Keylen, Nikoletta Zeschick, Anna Ruth Schlenz, Thomas Kühlein |
| 264 | 1 | |a Erlangen ; Nürnberg |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2022 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 653 | |a Physicians | ||
| 653 | |a Medical risk factors | ||
| 653 | |a Osteoporosis | ||
| 653 | |a Hip | ||
| 653 | |a Drug therapy | ||
| 653 | |a Osteology | ||
| 653 | |a Questionnaires | ||
| 653 | |a Treatment guidelines | ||
| 700 | 1 | |a Zeschick, Nikoletta |e Verfasser |4 aut | |
| 700 | 1 | |a Schlenz, Anna Ruth |e Verfasser |4 aut | |
| 700 | 1 | |a Kühlein, Thomas |e Verfasser |4 aut | |
| 787 | 0 | 8 | |i Sonderdruck aus |t PLoS ONE |g Vol. 17 (2022) |o 10.1371/journal.pone.0272985 |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-214048 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://d-nb.info/1279277416/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |q application/pdf |u https://open.fau.de/handle/openfau/21404 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034135973 | ||
| 883 | 0 | |8 1\p |a emakn |c 0,05849 |d 20230128 |q DE-101 |u https://d-nb.info/provenance/plan#emakn | |
| 883 | 0 | |8 2\p |a emasg |c 1,00000 |d 20230128 |q DE-101 |u https://d-nb.info/provenance/plan#emasg | |
| 883 | 1 | |8 3\p |a npi |d 20230127 |q DE-101 |u https://d-nb.info/provenance/plan#npi | |
Datensatz im Suchindex
| _version_ | 1804185008147005440 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | van der Keylen, Piet Zeschick, Nikoletta Schlenz, Anna Ruth Kühlein, Thomas |
| author_facet | van der Keylen, Piet Zeschick, Nikoletta Schlenz, Anna Ruth Kühlein, Thomas |
| author_role | aut aut aut aut |
| author_sort | van der Keylen, Piet |
| author_variant | d k p v dkp dkpv n z nz a r s ar ars t k tk |
| building | Verbundindex |
| bvnumber | BV048871078 |
| collection | ebook |
| ctrlnum | (OCoLC)1374570946 (DE-599)DNB1279277416 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02294nmm a2200553zc 4500</leader><controlfield tag="001">BV048871078</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230322s2022 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">23,O02</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1279277416</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-214048</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1374570946</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1279277416</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">616.7</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">van der Keylen, Piet</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany</subfield><subfield code="c">Piet van der Keylen, Nikoletta Zeschick, Anna Ruth Schlenz, Thomas Kühlein</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen ; Nürnberg</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Physicians</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medical risk factors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Osteoporosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Hip</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Drug therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Osteology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Questionnaires</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Treatment guidelines</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zeschick, Nikoletta</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schlenz, Anna Ruth</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kühlein, Thomas</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">PLoS ONE</subfield><subfield code="g">Vol. 17 (2022)</subfield><subfield code="o">10.1371/journal.pone.0272985</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-214048</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://d-nb.info/1279277416/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="q">application/pdf</subfield><subfield code="u">https://open.fau.de/handle/openfau/21404</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034135973</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">emakn</subfield><subfield code="c">0,05849</subfield><subfield code="d">20230128</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emakn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">emasg</subfield><subfield code="c">1,00000</subfield><subfield code="d">20230128</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emasg</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">npi</subfield><subfield code="d">20230127</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#npi</subfield></datafield></record></collection> |
| id | DE-604.BV048871078 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T21:44:14Z |
| indexdate | 2024-07-10T09:48:24Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034135973 |
| oclc_num | 1374570946 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| record_format | marc |
| spelling | van der Keylen, Piet Verfasser aut Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany Piet van der Keylen, Nikoletta Zeschick, Anna Ruth Schlenz, Thomas Kühlein Erlangen ; Nürnberg Friedrich-Alexander-Universität Erlangen-Nürnberg 2022 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager Physicians Medical risk factors Osteoporosis Hip Drug therapy Osteology Questionnaires Treatment guidelines Zeschick, Nikoletta Verfasser aut Schlenz, Anna Ruth Verfasser aut Kühlein, Thomas Verfasser aut Sonderdruck aus PLoS ONE Vol. 17 (2022) 10.1371/journal.pone.0272985 https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-214048 Resolving-System kostenfrei Volltext https://d-nb.info/1279277416/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext application/pdf https://open.fau.de/handle/openfau/21404 Verlag kostenfrei Volltext 1\p emakn 0,05849 20230128 DE-101 https://d-nb.info/provenance/plan#emakn 2\p emasg 1,00000 20230128 DE-101 https://d-nb.info/provenance/plan#emasg 3\p npi 20230127 DE-101 https://d-nb.info/provenance/plan#npi |
| spellingShingle | van der Keylen, Piet Zeschick, Nikoletta Schlenz, Anna Ruth Kühlein, Thomas Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany |
| title | Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany |
| title_auth | Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany |
| title_exact_search | Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany |
| title_exact_search_txtP | Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany |
| title_full | Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany Piet van der Keylen, Nikoletta Zeschick, Anna Ruth Schlenz, Thomas Kühlein |
| title_fullStr | Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany Piet van der Keylen, Nikoletta Zeschick, Anna Ruth Schlenz, Thomas Kühlein |
| title_full_unstemmed | Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany Piet van der Keylen, Nikoletta Zeschick, Anna Ruth Schlenz, Thomas Kühlein |
| title_short | Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany |
| title_sort | treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication survey among physicians and lay persons in germany |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-214048 https://d-nb.info/1279277416/34 https://open.fau.de/handle/openfau/21404 |
| work_keys_str_mv | AT vanderkeylenpiet treatmentthresholdsandminimalclinicallyimportanteffectsizesofantiosteoporoticmedicationsurveyamongphysiciansandlaypersonsingermany AT zeschicknikoletta treatmentthresholdsandminimalclinicallyimportanteffectsizesofantiosteoporoticmedicationsurveyamongphysiciansandlaypersonsingermany AT schlenzannaruth treatmentthresholdsandminimalclinicallyimportanteffectsizesofantiosteoporoticmedicationsurveyamongphysiciansandlaypersonsingermany AT kuhleinthomas treatmentthresholdsandminimalclinicallyimportanteffectsizesofantiosteoporoticmedicationsurveyamongphysiciansandlaypersonsingermany |